Aspartylglucosaminuria
From Wikipedia, the free encyclopedia
| This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (March 2008) |
| Aspartylglucosaminuria Classification and external resources |
|
| Aspartylglucosamine | |
| ICD-10 | E77.1 |
| OMIM | 208400 |
| DiseasesDB | 952 |
Aspartylglucosaminuria (AGU), also called aspartylglycosaminuria, is a rare, autosomal recessive[1] metabolic disorder caused by deficient activity of the enzyme aspartylglucosaminidase.
Contents |
[edit] Diagnosis
Clinical manifestations consist of psychomotor retardation, grotesque facial appearance, hepatosplenomegaly, ventral hernia and skeletal abnormalities. It is a member of Finnish disease heritage, a group of diseases or syndromes caused by mutation in a single gene characterized by higher frequency in Finland than the rest of the world.[1]
[edit] Pathophysiology
Deficiency of aspartylglucosaminidase (1-aspart-amido-beta-N-acetylglucosamine aminohydrase - E.C.3.5.1.26), an enzyme which cleaves the N-acetyl-glucosamine-asparagine linkage of oligosaccharide chains in glycoprotein and glycopeptide metabolism, causes Aspartylglycosaminuria. Biochemical tests show high urinary levels of aspartylglucosamine and low activity of aspartylglucosaminidase.
[edit] Epidemiology
Aspartylglycosaminuria is most common in patients of Finnish ancestry, affecting about 2.5% to 3% of the population.[1]
After trisomy 21 and fragile X syndrome, this is the most frequent multiple congenital anomaly/mental retardation syndrome.[citation needed]
[edit] See also
[edit] References
- ^ a b c Aronson NN Jr. (1999). "Aspartylglycosaminuria: biochemistry and molecular biology". Biochim Biophys Acta. 1455 (2-3): 139-154. PMID 10571008.
|
||||||||||||||

